Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Blue Bird Corp (NQ: BLBD )

41.18 +1.10 (+2.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Blue Bird Corp

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
What 4 Analyst Ratings Have To Say About Blue Bird
Via Benzinga
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining... 
Via Newsfile
Is CRISPR Therapeutics the NVIDIA of gene editing?
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Wall Street Favorites: 3 EV Stocks With Strong Buy Ratings for February 2024
Though the certainty of the electric vehicle industry may be waning, these three EV stocks offer strong potential nonetheless. 
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
Should you consider NASDAQ:BLBD for growth investing?
BLUE BIRD CORP (NASDAQ:BLBD) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
NASDAQ:BLBD stands out as a growth opportunity that won't break the bank.
NASDAQ:BLBD is not too expensive for the growth it is showing. 
Via Chartmill
Blue Bird: Q1 Earnings Insights
Via Benzinga
3 Goliath Growth Stocks Poised for Takeoff in February
These three top-tier growth stocks to buy offer investors incredible potential returns and are perfect for long-term investing. 
Via InvestorPlace
Blue Bird Announces Launch of Secondary Public Offering
From Blue Bird Corporation
Via Business Wire
Gene therapy: Why does it cost millions for a single treatment?
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. 
Via MarketBeat
Exposures Product Safety
Win-Win Situation? Nuvve's (NASDAQ: NVVE) Technology Can Potentially Turn Your Electric Vehicle Into A Revenue Stream That Helps Support The Power Grid
Electric vehicles seem poised to take over the roads, reducing global emissions and helping the world achieve a greener future. 
Via Benzinga
Topics Electric Vehicles Emissions
Exposures Electric Vehicles
Earnings Scheduled For February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
Earnings Outlook For Blue Bird
Via Benzinga
What's Going On With School Bus Manufacturer Blue Bird Shares Today?
Blue Bird Corporation (NASDAQ: BLBD) shares are trading lower on Wednesday. 
Via Benzinga
Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Thursday Morning
Via Investor Brand Network
Topics Energy
Exposures Fossil Fuels
12 Industrials Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Industrials Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Blue Bird Reports Fiscal 2024 First Quarter Record Results; Raises 2024 Guidance
From Blue Bird Corporation
Via Business Wire
Thinking Big With Nuvve's Vehicle-To-Grid Solution
The vehicle-to-grid (V2G) market is in its infancy and could potentially be poised for growth as the number of electric vehicles on the road multiplies. The cutting-edge and potentially game-changing... 
Via Benzinga
Glancy Prongay & Murray LLP Announces Investigation of Blue Bird Corporation (BLBD) (f/k/a Hennessy Capital Acquisition Corp.)
From Glancy Prongay & Murray LLP
Via Business Wire
3 Stocks to Buy for the Next Big Wave in Green Transportation
A renewable energy infrastructure is being built, but patient investors still have time to get involved with green transportation stocks. 
Via InvestorPlace
Top Stock Picks 2024: 3 Small-Cap Sensations with Huge Growth Potential
If you’re hunting for small-cap growth stocks right now, here are three names that are undervalued and have high upside potential. 
Via InvestorPlace
Blue Bird Announces Authorization of $60 Million Stock Repurchase Program
From Blue Bird Corporation
Via Business Wire
Blue Bird to Report Fiscal 2024 First Quarter Results on February 7, 2024
From Blue Bird Corporation
Via Business Wire
Wabash Stock Shoots Higher 6th Day In Row, Gets Rating Upgrade
Wabash stock's B Accumulation/Distribution Rating shows more buying than selling by professionals like mutual fund and ETF managers. 
Via Investor's Business Daily
Topics ETFs
Blue Bird Receives Record Order of 180 Electric School Buses
From Blue Bird Corporation
Via Business Wire
3 Growing Small-Cap Stocks to Invest in for 2024
Here are three stocks with a market cap under $1 billion that investors should be excited for in 2024. 
Via InvestorPlace
Blue Bird Delivers First Electric School Bus Fleet to Carter County Schools in Kentucky
From Blue Bird Corporation
Via Business Wire
Blue Bird Announces Launch of Secondary Public Offering
From Blue Bird Corporation
Via Business Wire
Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.